Fadaei-Kenarsary Meisam, Farbood Yaghoob, Taghi Mansouri Seyed Mohammad, Fathi Moghaddam Hadi
Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz, Iran; Physiology Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Physiology Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Pharmacology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Basic Clin Neurosci. 2015 Jan;6(1):21-8.
Methadone has been used as a drug to detoxify opioid tolerance. Naloxane precipitated morphine withdrawal behaviours were attenuated by venlafaxine as an antidepressant. On the contrary, after detoxifying the opioids, spontaneous withdrawal syndrome may occur with pain sensitivity. Therefore the present study aimed to examine the effects of chronic methadone (70 mg/kg, in drinking water, 7 days), venlafaxine (80 mg/kg/day, intraperitoneally, 7 days) and their combinations with the spontaneous morphine withdrawal syndrome and pain sensitivity.
Twenty eight young male Sprague-Dawley rats were randomly divided into 4 groups: control, venlafaxine treated, methadone treated and venlafaxine + methadone treated. Morphine sulfate (10 mg/kg/day, subcutaneously, 4 days) was injected to all animals. Then primary withdrawal behaviours and tail flick test were performed. The test was then followed by methadone or its vehicle administration. Second intervention was venlafaxine or its vehicle injection. Then final withdrawal behaviours and tail flick test were performed.
Combination of chronic methadone substitution and venlafaxine administration, significantly reduced freezing behaviour of spontaneous morphine withdrawal syndrome (P<0.01, 379±144%). Chronic methadone administration (P<0.05, 35±8% difference with venlafaxine treated group) induced hyperalgesia. A positive correlation (P=0.001, +63%) was observed between the animals final freezing scores and their response latencies to the painful stimulus.
Combination of chronic methadone and venlafaxine administrations reduces freezing withdrawal behaviour. Further investigations on analgesic interventions are needed to overcome this hyperalgesia.
美沙酮一直被用作一种药物来解除阿片类药物耐受性。作为一种抗抑郁药,文拉法辛可减轻纳洛酮诱发的吗啡戒断行为。相反,在解除阿片类药物后,可能会出现伴有疼痛敏感性的自发戒断综合征。因此,本研究旨在探讨慢性给予美沙酮(70毫克/千克,溶于饮用水中,7天)、文拉法辛(80毫克/千克/天,腹腔注射,7天)及其联合用药对自发吗啡戒断综合征和疼痛敏感性的影响。
将28只年轻雄性斯普拉格-道利大鼠随机分为4组:对照组、文拉法辛治疗组、美沙酮治疗组和文拉法辛+美沙酮治疗组。对所有动物皮下注射硫酸吗啡(10毫克/千克/天,4天)。然后进行初次戒断行为和甩尾试验。试验后给予美沙酮或其赋形剂。第二次干预是注射文拉法辛或其赋形剂。然后进行最终戒断行为和甩尾试验。
慢性美沙酮替代与文拉法辛联合给药,显著降低了自发吗啡戒断综合征中的僵住行为(P<0.01,379±144%)。慢性给予美沙酮会诱发痛觉过敏(P<0.05,与文拉法辛治疗组相比差异为35±8%)。在动物的最终僵住评分与其对疼痛刺激的反应潜伏期之间观察到正相关(P=0.001,+63%)。
慢性美沙酮与文拉法辛联合给药可减少僵住戒断行为。需要进一步研究镇痛干预措施以克服这种痛觉过敏。